Parathyroid hormone and the cellular immune system.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Nephron

• Publication date

  1995-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000188538PMID 7617112
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Parathyroid hormone dependent T cell proliferation in uremic rats.

  1993cited by this paper
• Decreased O2 consumption by PMNL from humans and rats with CRF: role of secondary hyperparathyroidism.

  1992cited by this paper
• Secondary hyperparathyroidism and the immune system in chronic renal failure.

  1991cited by this paper
• Effect of parathyroid hormone on human T cell activation.

  1990cited by this paper
• Parathyroid hormone inhibits B cell proliferation: implications in chronic renal failure.

  1990cited by this paper
• Effect of parathyroid hormone on elastase release from human polymorphonuclear leucocytes.

  1989cited by this paper
• Effect of parathyroidectomy on T cell functions in patients with primary hyperparathyroidism.

  1989cited by this paper
• Effect of parathyroid hormone on random migration of human polymorphonuclear leukocytes.

  1988cited by this paper
• In vitro effect of PTH on normal T cell functions.

  1988cited by this paper
• B-cell activation and immunoregulation in end-stage renal disease patients receiving hemodialysis.

  1987cited by this paper
• Parathyroid hormone stimulation of mitosis in rat thymic lymphocytes is independent of cyclic AMP

  1987cited by this paper
• Parathyroid hormone-lymphocyte interactions modulate bone resorption.

  1986cited by this paper
• Characterization of the requirements for human T cell mitogenesis by using suboptimal concentrations of phytohemagglutinin.

  1985cited by this paper
• Elastase as a marker for neutrophilic myeloid cells.

  1984cited by this paper
• Parathyroid hormone receptors in circulating human mononuclear leukocytes.

  1984cited by this paper
• Circulating bovine lymphocytes contain receptors for parathyroid hormone.

  1983cited by this paper
• The influence of larger molecules on cellular response in uremia.

  1983cited by this paper
• Augmented polymorphonuclear chemiluminescence in patients with secondary hyperparathyroidism.

  1981cited by this paper
• Effect of parathyroid hormone on rat heart cells.

  1981cited by this paper
• Host defenses and immunologic alterations associated with chronic hemodialysis.

  1980cited by this paper
• Reversible defect of neutrophil chemotaxis and random migration in primary hyperparathyroidism.

  1979cited by this paper
• Primary hyperparathyroidism and chronic lymphocytic leukemia

  1978cited by this paper
• Parathyroid adenoma and nonmedullary thyroid carcinoma

  1976cited by this paper
• Hypercalcaemia and parathyroid hyperplasia associated with renal adenocarcinoma

  1976cited by this paper
• Monoclonal IgG gammopathy and hyperparathyroidism.

  1972cited by this paper
• Malignant neoplasms and parathyroid adenoma

  1971cited by this paper
• The possible mediation by cyclic AMP of parathyroid hormone‐induced stimulation of mitotic activity and deoxyribonucleic acid synthesis in rat thymic lymphocytes

  1970cited by this paper

• Plasma proteomics reveals potential biomarkers for the preoperative diagnosis of parathyroid carcinoma

  2025cites this paper
• Interplay of calcium, Vitamin D, and parathormone in the milieu of infections and immunity: reassessed in the context of COVID-19.

  2024cites this paper
• The Interaction of Vitamin D and Corticosteroids: A Mortality Analysis of 26,508 Veterans Who Tested Positive for SARS-CoV-2

  2021cites this paper
• Beyond Bone: Infectious Diseases and Immunity in Parathyroid Disorders.

  2021cites this paper
• Hepatitis B virus vaccine immune response and mortality in dialysis patients: a meta-analysis

  2019cites this paper
• Functional Significance of Endocrine-Immune Interactions in Health and Disease.

  2019cites this paper
• Neutrophil gelatinase-associated lipocalin reflects the severity of anemia without iron deficiency and secondary hyperparathyroidism in hemodialysis patients

  2017cites this paper
• Type of Renal Replacement Therapy (Hemodialysis versus Peritoneal Dialysis) Does Not Affect Cytokine Gene Expression or Clinical Parameters of Renal Transplant Candidates

  2015cites this paper
• Parathyroid Hormone: A Dynamic Regulator of Bone, Immune, and Hematopoietic Cells

  2013cites this paper
• Gastrointestinal-related uremic toxins in peritoneal dialysis: a pilot study with a 5-year follow-up.

  2013cites this paper
• The impact of dietary induced hyperparathyroidism on healthy and diseased periodontia: an experimental study in rats.

  2012cites this paper
• Calcitriol treatment attenuates inflammation and oxidative stress in hemodialysis patients with secondary hyperparathyroidism.

  2011cites this paper
• Effects of Parathyroid Hormone on Immune Function

  2010cites this paper
• PREFABL: predictors of failure of antibiotic locks for the treatment of catheter-related bacteraemia.

  2010cites this paper
• Effect of parathyroid hormone and teriparatide on immune function of human adherent and non-adherent leukocytes.

  2010cites this paper
• Inhibition of antigen presentation and T cell costimulation blocks PTH‐induced bone loss

  2010cites this paper
• Dietary-induced hyperparathyroidism affects serum and gingival proinflammatory cytokine levels in rats.

  2010cites this paper
• Serum protein-bound uraemic toxins and clinical outcomes in haemodialysis patients.

  2010cites this paper
• Treatment with calcimimetics in kidney transplantation.

  2010cites this paper
• Risk factors associated to bone complications in renal transplant Pretransplant risk factors History of renal osteodystrophy Secondary hyperparathyroidism Osteomalacia Mixed bone disease Adynamic bone disease Aluminum toxicity Drug treatment Vitamin D and calcium Previous steroid treatment Immunosup

  2010cites this paper
• Immunomodulatory effects of secondary hyperparathyroidism on circulating CD4+ and CD8+ T-lymphocytes in chronic renal failure patients.

  2009cites this paper
• Induction of cardiovascular pathology in a novel model of low-grade chronic inflammation.

  2009cites this paper
• Serum phosphate levels and risk of infection in incident dialysis patients.

  2008influential citation
• T cells potentiate PTH-induced cortical bone loss through CD40L signaling.

  2008cites this paper
• P-cresol, a uremic toxin, decreases endothelial cell response to inflammatory cytokines.

  2002cites this paper
• In Vitro and In Vivo Analysis of the Immune System of Vitamin D Receptor Knockout Mice

  2001cites this paper
• Hypocalcemic syndromes.

  2001cites this paper
• Head-down tilt bed rest and immune responses

  2000cites this paper
• In vitro and in vivo TNFalpha synthesis modulation by methylguanidine, an uremic catabolyte.

  1999cites this paper
• Circulating ionized calcium and parathyroid hormone levels following coronary artery by-pass surgery.

  1999cites this paper
• Determinants of soluble CD23 antigen levels in hemodialysis patients: effect of 1.25 dihydroxyvitamin D3 and recombinant human erythropoietin treatment.

  1999cites this paper
• Idiopathic hypoparathyroidism with fungal seminal vesiculitis.

  1997cites this paper
• Effects of excess PTH on nonclassical target organs.

  1997cites this paper
• Dysfunction of polymorphonuclear leukocytes in uremia.

  1996cites this paper